Literature DB >> 21872230

Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis.

Ya-Nan Chang1, Ying Zhang, Yong-Jun Wang, Li-Ping Wang, Hua Duan.   

Abstract

OBJECTIVE: To determine whether preoperative hysteroscopic examination increases the risk for peritoneal dissemination of endometrial cancer cells and the effect of hysteroscopy on disease prognosis.
DESIGN: Meta-analysis.
SETTING: Literature search conducted via domestic and international databases for studies on preoperative hysteroscopy. PATIENT(S): A total of 2,944 women with endometrial cancer enrolled in selected studies. INTERVENTION(S): Preoperative hysteroscopic examination for 1,099 patients. MAIN OUTCOME MEASURE(S): Rate of positive peritoneal cytology. RESULT(S): Of 308 studies retrieved, 19 were included in the meta-analysis. The meta-analysis demonstrated that hysteroscopy resulted in a statistically significantly higher rate of positive peritoneal cytology results compared with no hysteroscopy. In addition, when a liquid medium was used for uterine distention during hysteroscopy, the difference between the two groups remained statistically significant. However, no statistically significant differences were seen when inflation pressure reached or exceeded 100 mm Hg or when the cancer stage was early. Trials that examined long-term outcomes reported no statistically significant differences in disease prognosis between the two groups. CONCLUSION(S): Hysteroscopic examination before surgery in patients with endometrial cancer may increase the risk of dissemination of malignant cells into the peritoneal cavity. The risk was statistically significantly associated with the use of a liquid medium for uterine cavity distention but not with early-stage disease. There is no evidence to support an association between preoperative hysteroscopic examination and a worse prognosis. There is no reason to avoid diagnostic hysteroscopy before to surgery in patients with endometrial cancer, especially in early stages.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872230     DOI: 10.1016/j.fertnstert.2011.07.1146

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  23 in total

1.  Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.

Authors:  Koji Matsuo; Shinya Matsuzaki; David J Nusbaum; Hiroko Machida; Yoshikazu Nagase; Brendan H Grubbs; Lynda D Roman; Jason D Wright; Philipp Harter; Maximilian Klar
Journal:  Eur J Cancer       Date:  2020-05-17       Impact factor: 9.162

2.  Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator : Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer.

Authors:  Franziska Siegenthaler; Silke Johann; Sara Imboden; Nicolas Samartzis; Haiyan Ledermann-Liu; Dimitri Sarlos; Markus Eberhard; Michael D Mueller
Journal:  Ann Surg Oncol       Date:  2022-09-04       Impact factor: 4.339

3.  Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.

Authors:  Koji Matsuo; David J Nusbaum; Shinya Matsuzaki; Erica J Chang; Lynda D Roman; Jason D Wright; Philipp Harter; Maximilian Klar
Journal:  Gynecol Oncol       Date:  2020-07-18       Impact factor: 5.482

4.  The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer.

Authors:  Akihisa Fujimoto; Mari Ichinose; Miyuki Harada; Tetsuya Hirata; Yutaka Osuga; Tomoyuki Fujii
Journal:  J Assist Reprod Genet       Date:  2014-08-10       Impact factor: 3.412

5.  Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma.

Authors:  Mingxia Li; Mingzhu Li; Lijun Zhao; Zhiqi Wang; Yue Wang; Danhua Shen; Jianliu Wang; Lihui Wei
Journal:  Int J Gynecol Cancer       Date:  2016-07       Impact factor: 3.437

6.  Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage.

Authors:  Andraz Dovnik; Bojana Crnobrnja; Branka Zegura; Iztok Takac; Maja Pakiz
Journal:  Radiol Oncol       Date:  2016-05-30       Impact factor: 2.991

7.  Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma?

Authors:  Jiao Chen; Leslie H Clark; Wei-Min Kong; Zhen Yan; Chao Han; Hui Zhao; Ting-Ting Liu; Tong-Qing Zhang; Dan Song; Si-Meng Jiao; Chunxiao Zhou
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

8.  Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.

Authors:  Ashley S Felix; Louise A Brinton; D Scott McMeekin; William T Creasman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2015-06-18       Impact factor: 13.506

9.  Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.

Authors:  Osamu Inoue; Toshio Hamatani; Nobuyuki Susumu; Wataru Yamagami; Seiji Ogawa; Takashi Takemoto; Akira Hirasawa; Kouji Banno; Naoaki Kuji; Mamoru Tanaka; Daisuke Aoki
Journal:  Reprod Biol Endocrinol       Date:  2016-01-15       Impact factor: 5.211

10.  Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.

Authors:  Francesca Falcone; Giuseppe Laurelli; Simona Losito; Marilena Di Napoli; Vincenza Granata; Stefano Greggi
Journal:  J Gynecol Oncol       Date:  2016-08-08       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.